Clinical Data

Businessman climbing steps to pluck a star from the sky

Biotech

Regeneron's ultrarare disease phase 3 hits, teeing up filings

The biotech plans to file for FDA approval of garetosmab in FOP by the end of 2025 on the strength of a pivotal trial that read out Wednesday.

Nick Paul Taylor Sep 17, 2025 9:31am

weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

Sep 17, 2025 9:00am

An arrow incrementally going up stairs before pointing straight up Blue background

Roivant reports phase 3 autoimmune win for ex-Pfizer asset

Sep 17, 2025 7:00am

Graphic image of an arrow nailing the bullseye of a target

Areteia posts ph. 3 asthma win for oral rival to biologic drugs

Sep 16, 2025 9:20am

next step ladder climb succeed win

PMV plots ovarian cancer filing after seeing midphase data

Sep 10, 2025 9:40am

White arrow on a road pointing to the rising sun

Dianthus' gMG asset blooms as phase 2 win sets up pivotal plans

Sep 8, 2025 9:24am